Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

VALSARTAN; HYDROCHLOROTHIAZIDE

VALSARTAN; HYDROCHLOROTHIAZIDE

Standard Dose
320MG; 25MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview VALSARTAN; HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 091654 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient VALSARTAN; HYDROCHLOROTHIAZIDE Form and strength TABLET; ORAL - 320MG; 25MG Sponsor TORRENT PHARMS LTD Submission history Latest submission status date: 2012-04-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview VALSARTAN; HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 091654 (ANDA). Marketing status: None (Tentative Approval) Active ingredient VALSARTAN; HYDROCHLOROTHIAZIDE Form and strength TABLET; ORAL - 320MG; 25MG Sponsor TORRENT PHARMS LTD Submission history Latest submission status date: 2012-04-10 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.